Granules Pharmaceuticals

Granules Pharmaceuticals, Inc. (GPI) is a wholly-owned subsidiary of Granges India. GPI is a facility approved by the U.S. FDA and DEA, covering an area of over 100,000 square feet, with R&D and manufacturing capabilities for low-volume oral solid dosage forms. GPI also distributes its products under the "GPI" label through front-end distribution. Our product portfolio includes small-batch complex products such as tablets, capsules, oral solutions, and powders for oral solutions produced at the Chantilly facility, medium to high-volume integrated products manufactured at the finished dose facilities in India, and TAA-compliant products produced at the Chantilly, Virginia plant.